Corneal Ulcer

Corneal Ulcer — scientific infographic poster

A corneal ulcer is an open sore on the cornea — the clear, dome-shaped surface at the very front of your eye — most often caused by a bacterial, fungal, viral, or parasitic infection. Because the cornea is the eye's primary focusing surface, even a small scar in the center of your field of view can permanently blur your vision to the equivalent of a strong uncorrected prescription. Corneal ulcers are a vision emergency: waiting to see whether symptoms improve on their own gives the infection time to advance. The single biggest risk factor in high-income countries is contact lens wear, particularly sleeping in lenses or rinsing them with tap water. Eye doctors treat a suddenly painful, red eye with changed vision — especially in a contact lens wearer — as an emergency to be examined the same day, with the lens taken out at once. Hours matter. Delay converts a treatable infection into a permanent scar.

  1. Overview and Definition
  2. The Cornea — Anatomy and Vulnerability
  3. Types of Infectious Keratitis
  4. Risk Factors
  5. Symptoms and Clinical Presentation
  6. Diagnosis
  7. Treatment by Organism
  8. Contact Lens Safety
  9. Complications
  10. Prognosis and Recovery
  11. Key Research Papers
  12. Connections

Overview and Definition

A corneal ulcer — technically called infectious keratitis with ulceration — is a breakdown of the corneal epithelium, and often the underlying stromal layers, caused by bacterial, fungal, viral, or parasitic organisms. The term "ulcer" reflects a true tissue defect: the protective outer cell layer has been breached, and the infectious agent is actively destroying corneal tissue beneath it.

This is a vision-threatening emergency. The cornea is only about 0.5 mm thick at its center — roughly the thickness of a credit card — and it performs the majority of the eye's focusing power. Even a small scar in the visual axis can permanently reduce vision to levels that require a strong corrective prescription, and a large or deep ulcer can perforate the cornea entirely. Worldwide, infectious keratitis accounts for an estimated 1.5 to 2 million new cases per year and is one of the leading causes of corneal blindness globally, particularly in tropical and low-resource settings where agricultural trauma and vitamin A deficiency are common triggers.

In high-income countries, the overwhelming majority of bacterial cases are driven by contact lens wear — a largely preventable cause. Recognizing the early warning signs and acting immediately is the single most important thing a patient can do to preserve their vision.

Back to Table of Contents

The Cornea — Anatomy and Vulnerability

Understanding why the cornea is so vulnerable to infection requires a brief look at its architecture. Five distinct layers make up the cornea, each with a different capacity to heal:

  1. Epithelium — five to six cell layers thick; forms a continuous tight-junction barrier; regenerates every seven days under normal conditions; the first and primary line of defense against infection.
  2. Bowman's layer — an acellular condensed collagen zone just beneath the epithelium; once injured it does not regenerate, leaving a permanent opacity.
  3. Stroma — constitutes about 90% of corneal thickness; composed of collagen lamellae arranged in a precise lattice that gives the cornea its optical transparency; infection here causes visible white opacity and structural weakening.
  4. Descemet's membrane — a thick basement membrane that is relatively resistant to enzymatic degradation; serves as the last barrier before the interior of the eye.
  5. Endothelium — a single layer of cells that actively pumps fluid out of the stroma to keep it clear; critically, these cells do not regenerate in adult humans. Endothelial failure from infection or inflammation causes permanent corneal edema and irreversible vision loss.

The cornea is also unusual in being entirely avascular — it derives its oxygen from the tear film and aqueous humor rather than blood vessels. This is essential for optical clarity, but it means that the eye's immune defenses arrive slowly once an infection is established. Neutrophils and macrophages must migrate from the limbal vasculature at the corneal rim; by the time a significant inflammatory response mounts, a virulent organism such as Pseudomonas aeruginosa may have already degraded substantial stromal tissue. Any disruption to the epithelium — from contact lens trauma, dry eye, chemical splash, ultraviolet (UV) exposure, or eyelid abnormalities — creates an entry point that the cornea cannot quickly seal against.

Back to Table of Contents

Types of Infectious Keratitis

Bacterial Keratitis

The most common form in contact lens wearers in developed countries. The organism most feared is Pseudomonas aeruginosa, which dominates soft contact lens-associated infections. Pseudomonas produces potent proteolytic enzymes (elastase, alkaline protease) that can liquefy stromal collagen within 24 to 48 hours, causing a ring abscess pattern and copious mucopurulent discharge. Other important bacteria include Staphylococcus aureus, Streptococcus pneumoniae, and various gram-negative enteric organisms. Slit-lamp appearance: a gray-white stromal infiltrate with an overlying fluorescein-staining epithelial defect. Hypopyon — a visible pus level in the anterior chamber — indicates severe infection and does not mean bacteria have entered the eye interior; it is a sterile inflammatory reaction to adjacent infection.

Fungal Keratitis

Caused by filamentous fungi (primarily Fusarium solani and Aspergillus species in tropical and subtropical climates) or by Candida in immunocompromised patients. The classic trigger is vegetative or soil trauma to the eye — an injury from a plant branch, grain husk, or agricultural tool. Slit-lamp appearance: a dry, rough-textured gray-white infiltrate with feathery or filamentous margins and satellite lesions. A critical danger is misdiagnosis as bacterial keratitis: the infiltrate can look similar in the early stages, and empiric antibiotics have no effect on fungi while allowing the infection to advance. The 2006 global epidemic of Fusarium keratitis linked to a contact lens solution withdrawn in 2006 demonstrated that this pathogen can affect otherwise healthy contact lens wearers, not only agricultural workers. At two eye centers in the northeastern United States, 15 cases of Fusarium keratitis were seen between July 2005 and May 2006 (16.4 cases a year, against 2.4 a year before); all 15 were contact lens users with no history of eye injury, and 6 of the 15 needed a corneal transplant.

Herpes Simplex Virus (HSV) Keratitis

The most common cause of infectious corneal blindness in the developed world. HSV-1 establishes latent infection in the trigeminal ganglion after primary exposure and can reactivate in response to ultraviolet light, fever, emotional stress, or immunosuppression. Two clinically distinct forms:

Critical warning: Topical corticosteroids are absolutely contraindicated in active epithelial HSV keratitis. Steroids suppress the immune response that limits viral replication, allowing the dendrite to expand into a large, irregular "geographic ulcer" that can destroy the entire corneal surface. Steroids are used cautiously, only with concurrent antiviral cover, for the immune-mediated stromal form.

Acanthamoeba Keratitis

Acanthamoeba are free-living amoebae found ubiquitously in water — tap water, swimming pools, hot tubs, lakes, and soil. In practical terms, virtually every case occurs in a contact lens wearer who has either rinsed their lenses or lens case with tap water, swum or showered while wearing lenses, or stored lenses in homemade saline. Two clinical hallmarks make this diagnosis distinctive:

The tragedy of Acanthamoeba keratitis is diagnostic delay. Average time from symptom onset to correct diagnosis has historically been three to four months. During that time, the patient is typically treated with antibiotics and sometimes steroids — neither of which helps and the latter of which worsens the outcome. Early diagnosis, ideally within weeks of symptom onset before the ring infiltrate forms, is the single most important determinant of whether the patient keeps functional vision without a corneal transplant.

Back to Table of Contents

Risk Factors

Contact lens wear is the dominant modifiable risk factor in high-income countries. Specific high-risk behaviors include: sleeping in lenses (in a 2008 case-control study at Moorfields Eye Hospital, London, overnight wear of any lens type carried 5.4 times the risk of microbial keratitis), wearing disposable lenses beyond their replacement schedule, rinsing lenses or cases with tap water (primary Acanthamoeba risk), swimming or showering with lenses in, and poor lens case hygiene (cases accumulate Pseudomonas biofilm rapidly). In a 12-month Australian population study (2008), microbial keratitis struck about 1.9 of every 10,000 daily-wear soft contact lens wearers a year, rising to 19.5 per 10,000 for overnight soft lens wear and 25.4 per 10,000 for overnight silicone hydrogel lens wear.

Ocular trauma is the dominant risk factor in developing countries and agricultural settings. Plant, vegetable, or soil injuries carry a high risk of fungal keratitis; dirty projectile injuries risk polymicrobial bacterial infection.

Other important risk factors include:

Back to Table of Contents

Symptoms and Clinical Presentation

A corneal ulcer produces a characteristic cluster of symptoms that distinguish it from the much more common and less dangerous condition of conjunctivitis (pink eye). These differences separate an eye that eye doctors examine the same day from one that can wait for a routine appointment:

A red eye with any visual change, severe pain, or photophobia is treated as not conjunctivitis until proven otherwise. Waiting it out with over-the-counter eye drops gives the infection time to advance; eye care providers treat this combination as an emergency.

Back to Table of Contents

Diagnosis

Diagnosis of a corneal ulcer requires slit-lamp examination by an ophthalmologist or experienced optometrist. The key diagnostic steps are:

  1. Slit-lamp biomicroscopy: The cornea is examined under high magnification with a bright, focused beam of light. This defines the ulcer size, depth, and character. Fluorescein dye (which stains green under cobalt blue light) outlines the epithelial defect. Rose bengal stain highlights dead epithelial cells and viral lesions. A Seidel test (the fluorescein pool dilutes and streams with aqueous if positive) can detect corneal perforation. The slit lamp can identify the dendritic pattern of HSV, the feathery infiltrate of fungal infection, or the perineural infiltrates of Acanthamoeba.
  2. Corneal scraping and culture: For any significant ulcer — larger than 1 mm, centrally located, not a textbook HSV dendrite in a low-risk patient — scraping the base and edges of the ulcer with a sterile spatula provides material for Gram stain (bacteria), KOH preparation and calcofluor white fluorescence microscopy (fungal hyphae, Acanthamoeba cysts), Giemsa stain, and bacterial and fungal culture. Polymerase chain reaction (PCR) is increasingly used for rapid detection of HSV, VZV, and Acanthamoeba DNA.
  3. Confocal microscopy: A non-invasive imaging modality that provides in vivo, high-resolution visualization of corneal cell layers. It can directly visualize fungal hyphae and — crucially — the double-walled cysts of Acanthamoeba in the stroma, enabling diagnosis within hours rather than weeks when used by an experienced examiner. Increasingly available at tertiary eye centers.
  4. Clinical diagnosis alone is appropriate for classic HSV epithelial dendrite in a patient without contact lenses and no immunosuppression — the pattern is sufficiently pathognomonic that scraping adds little and may worsen the epithelial defect.

Back to Table of Contents

Treatment by Organism

Bacterial Keratitis

Empiric therapy begins immediately, before culture results return. For most community-acquired bacterial keratitis in a contact lens wearer, fluoroquinolone monotherapy is the standard of care: moxifloxacin 0.5% or ciprofloxacin 0.3% applied every one hour while awake for the first 24 to 48 hours, then tapered as the ulcer responds. Fluoroquinolones provide excellent coverage for Pseudomonas (ciprofloxacin and moxifloxacin both have strong activity) and most gram-positive pathogens. Ofloxacin is not usually the first choice for contact lens-associated keratitis — its Pseudomonas activity is comparatively lower.

For severe, rapidly progressive, non-responding, or hospital-acquired cases: fortified topical drops compounded by a pharmacy are required. The classic regimen combines vancomycin 25–50 mg/mL (covering methicillin-resistant Staphylococcus and gram-positives) with tobramycin 14 mg/mL or ceftazidime 50 mg/mL (covering Pseudomonas and gram-negatives), instilled alternately every 30 to 60 minutes around the clock initially. Corticosteroids are withheld until the organism is identified and a favorable treatment response is established.

Two large trials have tested adding steroid drops to antibiotics for bacterial ulcers. In the Steroids for Corneal Ulcers Trial (SCUT, 500 patients, 2012), prednisolone 1% drops added to moxifloxacin made no overall difference to vision at 3 months, scar size, healing of the surface, or perforation, and raised no safety concerns; patients who started with very poor vision (counting fingers or worse) and those with completely central ulcers saw somewhat better at 3 months with the steroid. In SCUT II (280 patients, 2025), difluprednate 0.05% steroid drops added to moxifloxacin did not improve vision at 6 months compared with placebo, and adding corneal cross-linking with riboflavin to the steroid increased scar size.

Fungal Keratitis

Natamycin 5% ophthalmic suspension is the only U.S. Food and Drug Administration-approved topical antifungal for keratitis and is the first-line agent for filamentous fungi, particularly Fusarium. Clinical trial data from the Mycotic Ulcer Treatment Trial (MUTT I) demonstrated natamycin's superiority over voriconazole for Fusarium keratitis specifically. Voriconazole 1% (off-label; prepared by compounding pharmacy) was the comparison drop in MUTT I (323 patients, 2013): natamycin-treated eyes had better vision at 3 months and were less likely to perforate or need a therapeutic corneal transplant (odds ratio 0.42), with much of the difference coming from Fusarium cases, while non-Fusarium cases (including Aspergillus) fared similarly on both drugs. The trial's stated application to practice was that voriconazole should not be used as monotherapy in filamentous fungal keratitis. Amphotericin B 0.15% is preferred for Candida keratitis. Treatment duration is weeks to months — far longer than bacterial treatment. Topical corticosteroids are absolutely contraindicated. If medical treatment fails — infiltrate deepening despite adequate therapy, or perforation threatening — therapeutic penetrating keratoplasty (full-thickness corneal transplant) may be required, though outcomes in active fungal infection are poor.

Oral voriconazole tablets have also been tested on top of antifungal eye drops. In the Mycotic Ulcer Treatment Trial II (MUTT II, 240 patients with severe fungal ulcers in India and Nepal, 2016), adding the tablets did not lower the rate of corneal perforation or the need for a therapeutic corneal transplant (hazard ratio 0.82, P = .29), and adverse events were more common with the tablets (48.7% against 23.1% on placebo).

Herpes Simplex Keratitis (Epithelial Form)

Antiviral therapy is highly effective for epithelial HSV keratitis. Options include:

Gentle debridement — wiping away the loose infected epithelial cells with a cotton-tipped applicator — accelerates healing. Topical corticosteroids are contraindicated in active epithelial keratitis. For the stromal (disciform) immune form, topical corticosteroids with concurrent antiviral cover are appropriate. Long-term suppressive therapy with oral acyclovir 400 mg twice daily was tested in the Herpetic Eye Disease Study prevention trial (703 patients, 1998; PMID 9696640): over 12 months, 19% of patients on acyclovir had a recurrence of any form of eye herpes, against 32% on placebo; among the 337 patients with past stromal keratitis, stromal recurrences were 14% against 28%; and there was no rebound in the 6 months after the drug was stopped. The trial authors concluded that long-term prophylaxis matters most for people with a history of stromal keratitis, since it can prevent further episodes and vision loss.

Acanthamoeba Keratitis

Treatment is prolonged and intensive. The standard regimen is:

A single stronger drop has since been tested against the two-drug combination. In the Orphan Drug for Acanthamoeba Keratitis (ODAK) trial (135 patients at 6 European centers, 2024), PHMB (polihexanide) 0.08% alone cured about as many eyes within 12 months without surgery as PHMB 0.02% plus propamidine 0.1% (86.7% against 86.6% after adjustment); median final vision was 20/20, and 8 of 127 patients (6.3%) needed a corneal transplant.

Minimum treatment duration is three to six months, because the cyst form of Acanthamoeba is extraordinarily resistant to most disinfectants and requires sustained drug exposure to eradicate. Topical corticosteroids are generally withheld (though there is limited debate about their use in managing the immune response in very late disease). Prognosis is directly tied to how early treatment begins: patients treated before the ring infiltrate appears generally do well with medical therapy alone; those treated late frequently require penetrating keratoplasty, and even then outcomes are guarded because residual organisms in the stroma can infect the donor button.

Back to Table of Contents

Contact Lens Safety

Contact lens-related keratitis is almost entirely preventable. The following behaviors are the primary drivers of risk:

In a 12-month Australian population study (2008, 285 cases), the yearly rate of microbial keratitis per 10,000 wearers was 1.2 for daily-wear rigid gas-permeable lenses, 1.9 for daily-wear soft lenses, 2.0 for daily disposable lenses, 19.5 for overnight wear of soft lenses and 25.4 for overnight wear of silicone hydrogel lenses; loss of vision occurred in 0.6 per 10,000 wearers. In the Moorfields case-control study, rigid lenses carried 0.16 times the risk of planned-replacement soft lenses. Rigid gas-permeable lenses carry lower risk than soft lenses because they are less adherent to the corneal surface and are not typically worn overnight.

Back to Table of Contents

Complications

Untreated or inadequately treated corneal ulcers can cause severe, permanent harm:

Back to Table of Contents

Prognosis and Recovery

Outcomes depend heavily on the causative organism, the ulcer's size and location, and — above all — how quickly appropriate treatment begins.

Bacterial keratitis: With prompt, appropriate antibiotic therapy, most peripheral bacterial ulcers heal without permanent visual loss. Central ulcers, even when treated effectively, leave varying degrees of scarring in the visual axis. Pseudomonas keratitis is particularly destructive and can progress to perforation within 48 hours without treatment; with aggressive fluoroquinolone therapy, most cases do respond, but central ulcers commonly leave significant opacity.

Fungal keratitis: Generally carries a worse prognosis than bacterial keratitis. Medical treatment failure requiring therapeutic penetrating keratoplasty occurs in approximately 15 to 27% of cases across published series. Outcomes in keratoplasty for active fungal infection are poor; the procedure is primarily used to excise actively infected tissue.

HSV keratitis: First episode of epithelial keratitis typically heals well with antiviral therapy, leaving minimal scarring. However, HSV is a recurrent disease — each episode of stromal keratitis causes cumulative immune-mediated scarring. After three or more episodes of stromal disease, significant visual impairment is common. Long-term suppressive therapy (acyclovir 400 mg twice daily) lowered the 12-month recurrence rate from 32% on placebo to 19% in the Herpetic Eye Disease Study, whose authors judged it most important for people with a history of stromal keratitis.

Acanthamoeba keratitis: Historically, 50 to 80% of patients required penetrating keratoplasty and outcomes were poor. With growing availability of confocal microscopy enabling earlier diagnosis, and prompt initiation of PHMB-based therapy, outcomes have improved substantially. Patients diagnosed before ring infiltrate formation who receive immediate aggressive treatment have reasonable prospects of retaining useful vision with medical therapy alone. The key message remains: early diagnosis is everything.

Penetrating keratoplasty (full-thickness corneal transplant) is required in approximately 5 to 15% of infectious keratitis cases in developed-country settings — primarily for cases with perforation, extensive scarring in the visual axis following healed infection, or failure of medical therapy for fungal or Acanthamoeba infections. Graft survival in eyes with prior infection is somewhat lower than for other indications due to corneal neovascularization and the increased risk of immune rejection.

Back to Table of Contents

Key Research Papers

  1. Herpetic Eye Disease Study Group. "Acyclovir for the prevention of recurrent herpes simplex virus eye disease." N Engl J Med. 1998;339:300–306. — PubMed PMID: 9696640
  2. Bourcier T et al. "Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases." Br J Ophthalmol. 2003;87:834–838. — PubMed PMID: 12812878
  3. Liesegang TJ. "Herpes simplex virus epidemiology and ocular importance." Cornea. 2001;20:1–13. — PubMed PMID: 11188989
  4. Gorscak JJ et al. "An outbreak of Fusarium keratitis associated with contact lens use in the northeastern United States." Cornea. 2007;26:1187–1194. — PubMed PMID: 18043174
  5. Seal D, Stapleton F, Dart J. "Possible environmental sources of Acanthamoeba spp in contact lens wearers." Br J Ophthalmol. 1992;76:424–427. — PubMed PMID: 1627513
  6. Bacon AS et al. "A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992." Eye (Lond). 1993;7:719–725. — PubMed PMID: 8119418
  7. Srinivasan M et al. "Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT)." Arch Ophthalmol. 2012;130:143–150. — PubMed PMID: 21987582
  8. Prajna NV et al. "The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole." JAMA Ophthalmol. 2013;131:422–429. — PubMed PMID: 23710492
  9. Khor WB et al. "An outbreak of Fusarium keratitis associated with contact lens wear in Singapore." JAMA. 2006;295:2867–2873. — PubMed PMID: 16804153
  10. Stapleton F et al. "The incidence of contact lens-related microbial keratitis in Australia." Ophthalmology. 2008;115:1655–1662. — PubMed PMID: 18538404
  11. Dart JK et al. "Risk factors for microbial keratitis with contemporary contact lenses: a case-control study." Ophthalmology. 2008;115:1647–1654. — PubMed PMID: 18597850
  12. Prajna NV et al. "Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial." JAMA Ophthalmol. 2016;134:1365–1372. — PubMed PMID: 27787540
  13. Dart JKG et al. "The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1." Ophthalmology. 2024;131:277–287. — PubMed PMID: 37802392
  14. Prajna NV et al. "Steroids and Cross-Linking for Ulcer Treatment: The SCUT II Randomized Clinical Trial." JAMA Ophthalmol. 2025;143:723–730. — PubMed PMID: 40705354

PubMed topic searches:

  1. PubMed: Corneal ulcer bacterial keratitis treatment
  2. PubMed: Acanthamoeba keratitis contact lens
  3. PubMed: Herpes simplex keratitis recurrence prevention
  4. PubMed: Fungal keratitis natamycin voriconazole

Back to Table of Contents

Connections

Back to Table of Contents